Robert D Eziel

Title: The Innovations of Robert D Eziel

Introduction

Robert D Eziel is a notable inventor based in Ville Mont-Royal, Canada. He has made significant contributions to the field of antiviral research, particularly in the development of peptide derivatives for treating herpes infections. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Eziel's latest patents include innovative formulations aimed at combating herpes infections. One of his patents, titled "Isosteric antiherpes peptide derivatives," discloses peptide derivatives that are useful for treating herpes infections. The formula includes various components such as terminal groups and amino acid residues, which enhance the effectiveness of the treatment. Another patent, "Antiherpes compositions and method of use," describes a combination of an antiviral nucleoside analog and a ribonucleotide reductase inhibiting peptide derivative. This combination is designed to provide a robust approach to combat herpes infections.

Career Highlights

Robert D Eziel is associated with Bio-Mega/Boehringer Ingelheim Research Inc., where he has been instrumental in advancing research in antiviral therapies. His work has not only contributed to the scientific understanding of herpes treatments but has also paved the way for potential new therapies in the field.

Collaborations

Eziel has collaborated with notable colleagues such as Yvan Guindon and Pierre Louis Beaulieu. These collaborations have further enriched his research and contributed to the development of innovative solutions in antiviral treatments.

Conclusion

Robert D Eziel's contributions to antiviral research, particularly in the area of herpes treatment, highlight his role as an influential inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.